09 /L NT-proBNP, pg/mL CRP, mg/dL Glucose, mg/dL HbA
09 /L NT-proBNP, pg/mL CRP, mg/dL Glucose, mg/dL HbA1c, BUN, mg/dL Creatinine, mg/dL AST, IU/L ALT, IU/L Total cholesterol, mg/dL TG, mg/dL HdL, mg/dL LdL, mg/dL Peak CK, IU/L Peak CK-MB, mg/mL Peak Trop-I, ng/mL MNITMT manufacturer Echocardiographic measure End-diastolic dimension, mm End-systolic dimension, mm Left atrial dimension, mm Left ventricle mass index, g/m2 E/E ratio Ejection fraction, Wall motion score index Values are mean SD or n . IMR 29 U (n = 190) 190 (one hundred) 157 (82.6) 29 (32.6) 4 (three.four) 92 (91.1) 98 (97.0) 100 (99.0) 11.7 three.six 14.8 1.7 252.four 68.5 445.five 2099.7 0.44 0.92 156.8 52.eight 6.4 1.2 16.0 six.3 1.02 0.25 49.0 64.two 33.9 20.1 185.1 37.7 130.7 94.1 43.1 9.9 116.4 34.eight 1958.two 2052.four 214.7 171.9 56.three 61.3 50.0 4.7 36.1 five.two 38.two 3.6 102.eight 17.two 10.two two.9 48.4 7.eight 1.50 0.29 IMR 29 U (n = 126) 126 (100) 106 (84.1) 17 (29.8) 1 (1.1) 63 (91.3) 62 (89.9) 66 (95.7) 11.7 3.9 14.6 1.9 253.6 70.1 1223.1 4512.5 0.65 2.59 172.four 65.4 6.six 1.6 15.5 6.six 1.00 0.32 77.6 115.eight 43.four 40.five 188.0 45.5 130.four 106.1 43.7 ten.1 118.2 40.9 3842.9 2741.five 327.two 183.9 74.0 79.6 50.5 5.2 37.0 five.eight 38.1 3.9 109.two 26.9 11.8 three.6 45.6 six.9 1.64 0.27 N/A 0.728 0.726 0.284 0.961 0.051 0.156 0.888 0.350 0.874 0.245 0.503 0.028 0.374 0.935 0.515 0.031 0.037 0.541 0.978 0.657 0.677 0.000 0.000 0.046 0.322 0.157 0.849 0.115 0.001 0.001 0.316 (100) 263 (83.2) 46 (31.5) five (two.4) 155 (91.two) 160 (94.1) 166 (97.six) 11.7 3.eight 14.7 1.8 252.9 69.0 741.0 3235.9 0.52 1.74 163.0 58.five six.five 1.four 15.6 six.4 1.01 0.28 59.three 87.3 37.three 29.five 186.3 40.9 130.6 98.9 43.4 ten.0 117.two 37.three 2636.1 2489.three 259.three 184.eight 63.2 69.five 50.2 four.9 36.4 five.four 38.1 three.7 105.three 21.6 ten.9 3.three 47.three 7.six 1.55 0.Table 2. Post-procedural coronary physiology measurements. Total Pa hyperemia, mmHg Pd hyperemia, mmHg Tmn rest, sec Tmn hyperemia, sec FFR CFR IMR IMRc 88.eight 15.five 82.0 15.five 0.60 0.36 0.36 0.25 0.92 0.07 1.94 1.29 27.7 17.6 29.four 20.0 IMR 29 U (n = 190) 88.three 14.three 80.7 14.2 0.45 0.26 0.22 0.07 0.91 0.07 two.18 1.47 16.7 5.1 17.1 5.two IMR 29 U (n = 126) 89.7 17.2 84.1 17.0 0.84 0.37 0.59 0.26 0.93 0.07 1.56 0.80 44.four 16.6 48.1 19.five 0.451 0.056 0.000 0.000 0.063 0.000 0.000 0.000 pValues are mean D. Pa: aortic stress; Pd: distal stress; Tmn: imply transit time; CFR: coronary flow reserve; FFR: fractional flow reserve; IMR: index of -Irofulven DNA Alkylator/Crosslinker,Apoptosis microcirculatory resistance; IMRc: corrected IMR.three.two. Angiographic Traits In angiographic findings (Table three), single-vessel disease was probably the most typical (64 ), and a lot of the infarct-related artery was left anterior descending artery (LAD). The distri-J. Clin. Med. 2021, ten,five ofbution of culprit artery did not show any substantial differences amongst the two groups. Even so, high IMR individuals had a larger percentage of baseline TIMI flow grade 0/1 (low IMR 58.6 vs. higher IMR 81.1 , p 0.001) and greater rate of final TIMI myocardial perfusion (TMP) grade 0/1 (low IMR 1.two vs. high IMR 25.0 , p 0.001) than those with low IMR (Table 3).Table 3. Angiographic qualities. Total Baseline qualities culprit artery, n LAD LCX RCA variety of vessel, n 1 2 three two TIMI grade ahead of PCI, n 0/1 2 3 Post-procedural qualities Stent diameter, mm Stent length, mm TIMI grade right after PCI, n 0/1 two three TMP grade following PCI, n 0/1 two three IMR 29 U (n = 190) IMR 29 U (n = 126) 0.338 248 (78.2) 20 (six.three) 49 (15.5) 202 (64.1) 86 (27.3) 27 (eight.6) 113 (35.9) 201 (67.9) 65 (22.0) 30 (ten.1) 151 (79.1) 9 (four.7) 31 (16.2) 130 (68.four) 44 (23.two) 16 (8.four) 62 (32.6) 102 (58.six) 46 (26.four) 26 (14.9) 97 (77.0) 11 (8.7) 18 (14.three) 0.111 72 (57.6) 42 (.
